Precision medicine in lymphoid malignancies
Immuno-oncology opportunities for the treatment of lymphoma
Measuring treatment response rates in multiple myeloma
Overview of RESONATE-2 clinical trial of ibrutinib in CLL
John Gribben et al.
Improving patient outcomes in acute lymphoblastic leukemia at ASH 2015